About Icotinib API
High-Purity Icotinib API for Targeted Cancer Therapy
Icotinib API is a pharmaceutical-grade epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor indicated for the treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC). It selectively inhibits EGFR signaling pathways, suppressing tumor cell proliferation and promoting apoptosis in cancer cells.
Icotinib is widely formulated into oral tablet dosage forms and plays an important role in precision oncology and targeted cancer therapy.
Manufactured under WHO-GMP-certified facilities, our Icotinib API offers exceptional purity, stability, and batch-to-batch consistency. Each batch is supplied with complete regulatory documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), and Technical Data Sheet (TDS).
Key Features
- High-purity pharmaceutical-grade API
- Potent EGFR tyrosine kinase inhibitor
- Targeted anticancer activity
- Excellent chemical stability
- Low impurity profile
- WHO-GMP certified manufacturing
- Complete CoA & MSDS
- Batch-to-batch consistency
- Suitable for oral formulations
- Worldwide bulk supply
Applications
- Non-Small Cell Lung Cancer (NSCLC)
- EGFR mutation-positive cancers
- Targeted oncology therapy
- Oral tablet formulations
- Oncology pharmaceutical manufacturing
- Generic drug development
- Clinical research
- Pharmaceutical research
Why Choose Swapnroop Pharma
- WHO-GMP Certified Manufacturing
- Advanced Oncology API Manufacturing
- High-Purity Pharmaceutical APIs
- Comprehensive Quality Control
- Complete Regulatory Documentation
- Competitive Bulk Pricing
- Reliable Worldwide Export
- Technical & Regulatory Support
- Consistent Product Quality
- Customized Packaging Solutions
Packaging & Supply
Available Packaging
- 1 kg
- 5 kg
- 10 kg
- 25 kg
- Custom Bulk Packaging Available
Documentation Provided
- Certificate of Analysis (CoA)
- Material Safety Data Sheet (MSDS)
- Technical Data Sheet (TDS)
- Product Specification Sheet
- Batch Manufacturing Record
Frequently Asked Questions (FAQs)
1. What is Icotinib API used for?
Icotinib API is used in pharmaceutical formulations for the treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC).
2. How does Icotinib work?
Icotinib selectively inhibits the EGFR tyrosine kinase, blocking cancer cell signaling pathways responsible for tumor growth and proliferation.
3. Is regulatory documentation available?
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation.
4. Is bulk commercial supply available?
Yes. We supply Icotinib API in commercial quantities with worldwide export support.
Get Bulk Quote via WhatsApp
